Allergy Therapeutics Pink Sheet Forward View - Accumulation Distribution
| AGYTF Stock | USD 0.11 0.00 0.00% |
Allergy Pink Sheet outlook is based on your current time horizon. We suggest always using this module together with an analysis of Allergy Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 17th of February 2026 the relative strength index (rsi) of Allergy Therapeutics' share price is below 20 . This suggests that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Allergy Therapeutics hype-based prediction, you can estimate the value of Allergy Therapeutics plc from the perspective of Allergy Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Allergy Therapeutics after-hype prediction price | USD 0.11 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Allergy |
Allergy Therapeutics Additional Predictive Modules
Most predictive techniques to examine Allergy price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Allergy using various technical indicators. When you analyze Allergy charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Allergy Therapeutics Volatility | Backtest Allergy Therapeutics | Information Ratio |
Allergy Therapeutics Trading Date Momentum
| On February 17 2026 Allergy Therapeutics plc was traded for 0.11 at the closing time. The highest daily price throughout the period was 0.11 and the lowest price was 0.11 . There was no trading activity during the period 0.0. Lack of trading volume on 02/17/2026 did not affect price variability. The overall trading delta to current closing price is 0.00% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Allergy Therapeutics to competition |
Other Forecasting Options for Allergy Therapeutics
For every potential investor in Allergy, whether a beginner or expert, Allergy Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Allergy Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Allergy. Basic forecasting techniques help filter out the noise by identifying Allergy Therapeutics' price trends.Allergy Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Allergy Therapeutics pink sheet to make a market-neutral strategy. Peer analysis of Allergy Therapeutics could also be used in its relative valuation, which is a method of valuing Allergy Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Allergy Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Allergy Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Allergy Therapeutics shares will generate the highest return on investment. By undertsting and applying Allergy Therapeutics pink sheet market strength indicators, traders can identify Allergy Therapeutics plc entry and exit signals to maximize returns.
Story Coverage note for Allergy Therapeutics
The number of cover stories for Allergy Therapeutics depends on current market conditions and Allergy Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Allergy Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Allergy Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Allergy Therapeutics Short Properties
Allergy Therapeutics' future price predictability will typically decrease when Allergy Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Allergy Therapeutics plc often depends not only on the future outlook of the potential Allergy Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Allergy Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 644.1 M | |
| Short Long Term Debt | 952 K | |
| Shares Float | 115.8 M |
Other Information on Investing in Allergy Pink Sheet
Allergy Therapeutics financial ratios help investors to determine whether Allergy Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Allergy with respect to the benefits of owning Allergy Therapeutics security.